S&P 500
7,757.17
+44.60
+0.58%
Dow
52,856.10
+360.20
+0.69%
Nasdaq
26,702.86
+278.04
+1.05%
NYSE Composite
24,253.12
+62.52
+0.26%
Russell 2000
2,781.02
+7.60
+0.27%
VIX
18.48
+1.80
+10.79%
STE · STERIS plc
NEW YORK STOCK EXCHANGE, INC. - Real Time Price • USD
$221.49
-3.61
(-1.60%)
● At close: October 21 at 4:00:00 PM EDT
DAY'S RANGE
$221.49
$221.07
$225.63
52-WEEK RANGE
$221.49
$195.14
$269.44
What's happening
- STE is down 1.60% today, trading at $221.49. — Live quote
- Volume today (69,876) is well below its 3-month average of 716,650. (Finnhub fundamentals)
- Reports earnings on 2026-11-11, 20 days away. (Finnhub earnings calendar)
- Last quarter's EPS beat estimates: $2.59 actual vs. $2.53 estimated (+2.5%). (Finnhub earnings history)
Deterministic template sentences filled in from the same sourced figures shown elsewhere on this page -- not an AI-written summary, no live model call.
Key Statistics
Analyst Recommendations
Strong buy 3
Buy 7
Hold 4
Sell 0
Strong sell 0
Aggregate ratings for 2026-10-01 (14 analysts polled by Finnhub) — consensus count.
Performance Overview (Trailing returns vs S&P 500 benchmark)
YTD RETURN
STE
-11.18%
vs S&P 500
-23.96%
1-YEAR RETURN
STE
-7.03%
vs S&P 500
-21.60%
6-MONTH RETURN
STE
+2.37%
3-MONTH RETURN
STE
+6.34%
Earnings Trends (Quarterly EPS Actual vs Estimate)
2026-07-26 (Q1 2027)
$2.59
Est. $2.53
BEAT +2.5%
2026-04-26 (Q4 2026)
$2.83
Est. $2.88
MISS -1.6%
2026-01-26 (Q3 2026)
$2.53
Est. $2.56
MISS -1.1%
2025-10-26 (Q2 2026)
$2.47
Est. $2.37
BEAT +4.0%
Valuation Measures & Ratios
Enterprise Value4$23.08B
Forward P/E517.88
PEG Ratio61.14
Price / Sales (TTM1)3.59
Price / Book72.85
EV4 / Revenue3.82
EV4 / EBITDA14.17
Profit Margin13.33%
Operating Margin18.85%
Return on Equity (ROE8)11.28%
Return on Assets (ROA9)7.58%
Avg Volume (3M)716,650
Quarterly history (5 periods)
| Measure | Jun '26 | Dec '25 | Sep '25 | Jun '25 | Dec '24 |
|---|---|---|---|---|---|
| Market cap | — | $24.82B | $24.30B | $23.57B | $20.10B |
| P/E | — | 33.73 | 35.08 | 36.47 | 42.99 |
| Price/Sales | — | 4.34 | 4.38 | 4.39 | 3.72 |
| Price/Book | — | 3.47 | 3.47 | 3.39 | 3.13 |
| EV/Revenue | — | 4.60 | 4.66 | 4.69 | 4.10 |
| EV/EBITDA | — | 17.30 | 17.74 | — | — |
| ROE | — | 10.28% | 9.88% | 9.29% | 7.29% |
| ROA | — | 6.95% | 6.65% | 6.21% | 4.67% |
Trailing-twelve-month ratios computed from SEC EDGAR quarterly figures and historical daily close prices (Alpaca). Diluted shares are derived from Net income ÷ EPS (diluted) for each quarter, not separately reported. Forward P/E/PEG unavailable (no free data source).
Glossary — what these abbreviations mean
- 1. TTM
- Trailing twelve months — the sum of the last four reported quarters, not a calendar year or the single latest quarter.
- 2. EPS
- Earnings per share — net income divided by diluted shares outstanding.
- 3. Beta
- A stock's historical volatility relative to the overall market. Above 1 means it has moved more than the market; below 1, less.
- 4. EV (Enterprise Value)
- Market cap plus total debt minus cash — roughly what it would cost to buy the whole company, debt included.
- 5. Forward P/E
- Price divided by analysts' estimated earnings for the next 12 months, instead of trailing actual earnings.
- 6. PEG Ratio
- P/E divided by expected earnings growth rate. A lower number can indicate a stock is cheap relative to how fast it's expected to grow.
- 7. Price / Book
- Share price divided by book value (assets minus liabilities) per share.
- 8. ROE
- Return on equity — net income divided by shareholders' equity, a measure of how efficiently a company turns equity into profit.
- 9. ROA
- Return on assets — net income divided by total assets, a measure of how efficiently a company turns assets into profit.
- 10. MRQ
- Most recent quarter — the single latest reported period, as opposed to TTM. The Financials section's "Quarterly" view below shows MRQ-style figures.
- 11. YoY
- Year over year — percent change versus the same period one year earlier, used for growth figures like those on Compare cards and the Screener.
Short Interest
Shares Short2,857,327
Change from Prior Settlement+2.47%
% of Float—
Days to Cover (Short Ratio)4.15
Source: FINRA Rule 4560 consolidated short interest, settlement date 2026-09-30. Reported bi-monthly with a reporting lag — not real-time.
Quotes and the 1-day extended-hours chart: Yahoo Finance. Longer historical charts: Alpaca (IEX feed) — real-time but IEX-only volume (~2.5% of consolidated market volume). Fundamentals + earnings: Finnhub.
Price history
Events
Drag horizontally to zoom into a section; use Reset view to restore all observations.
Technical signal summary
Calculating from the latest year of daily price history…
Show Technical Analysis Breakdown ▾ 10 Indicators
Not investment advice — read several signals together.
Indicators None active
Loading chart…
History limited by data provider; markers are heuristics, not signals.
Peer and sector context
No reviewed peer group is available for this symbol.
Balanced evidence
A deterministic summary of sourced facts—not an AI verdict.
Potential strengths
- Revenue growth is 7.3% on the provider's reported measure. Finnhub fundamentals ↗
- Net profit margin is 13.3%. Finnhub fundamentals ↗
Potential concerns
- Trailing 52-week price return is -7.0%. Finnhub market metrics ↗
- Latest SEC filing is Form 8-K, filed 2026-10-13; review it for current changes and risks. SEC EDGAR ↗
Rule-based facts only; absence from either side is not evidence, and this is not a recommendation.
More on STE
No accessible free API for these — links go to the source directly.
Financials
Fundamental trends
Visualized from the same SEC figures in the tables below.
Income statement
| Line item | Jun '26 | Dec '25 | Sep '25 | Jun '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.49B | $1.50B | $1.46B | $1.39B | $1.37B | $1.33B | $1.28B | $1.42B |
| Gross profit | $684.2M | $655.5M | $645.9M | $628.0M | $610.3M | $578.8M | $572.4M | $582.9M |
| Operating income | $285.8M | $273.2M | $265.8M | $246.0M | $245.3M | $219.7M | $185.5M | — |
| Net income | $200.1M | $192.9M | $191.9M | $177.4M | $173.5M | $150.0M | $145.4M | -$1.4M |
| EPS (diluted) | — | $1.96 | $1.94 | $1.79 | $1.75 | $1.51 | $1.46 | $-0.01 |
| EPS (basic) | — | $1.96 | $1.95 | $1.80 | $1.76 | $1.52 | $1.47 | $-0.01 |
| Operating margin | $19 | $18 | $18 | $18 | $18 | $17 | $14 | — |
| Net margin | $13 | $13 | $13 | $13 | $13 | $11 | $11 | -$0 |
Balance sheet
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $10.74B | $10.74B | $10.59B | $10.41B | $10.40B | $10.15B | $10.01B | $10.24B |
| Total liabilities | $3.51B | $3.54B | $3.42B | $3.39B | $3.44B | $3.53B | $3.58B | $3.63B |
| Stockholders' equity | $7.21B | $7.18B | $7.15B | $7.01B | $6.96B | $6.60B | $6.42B | $6.59B |
| Total current assets | $2.45B | $2.39B | $2.29B | $2.11B | $2.06B | $2.00B | $1.90B | $1.94B |
| Total current liabilities | $1.28B | $1.15B | $922.3M | $888.9M | $926.6M | $1.02B | $891.1M | $805.5M |
| Cash & equivalents | $482.3M | $439.6M | $423.7M | $319.2M | $279.7M | $171.7M | $155.2M | $172.2M |
| Accounts receivable | $1.01B | $1.09B | $990.6M | $947.3M | $947.1M | $1.04B | $915.2M | $923.3M |
| Inventory | $712.1M | $631.8M | $673.5M | $658.5M | $641.2M | $581.3M | $649.6M | $688.9M |
| Property, plant & equipment | $2.17B | $2.16B | $2.13B | $2.09B | $2.05B | $1.96B | $1.92B | $1.93B |
| Goodwill | $4.19B | $4.19B | $4.23B | $4.22B | $4.22B | $4.10B | $4.04B | $4.15B |
| Intangible assets | $1.56B | $1.62B | $1.69B | $1.75B | $1.82B | $1.85B | $1.92B | $2.00B |
| Other non-current assets | $215.1M | $211.4M | $93.6M | $87.9M | $88.6M | $83.0M | $67.7M | $60.3M |
| Accounts payable | $344.1M | $338.8M | $285.1M | $308.9M | $300.9M | $280.8M | $238.3M | $235.1M |
| Accrued liabilities | $420.5M | $401.9M | $405.0M | $360.3M | $371.0M | $368.1M | $334.6M | $307.5M |
| Short-term debt | $243.4M | $118.9M | $0 | $0 | $0 | $125.0M | $125.0M | $80.0M |
| Long-term debt | $1.65B | $1.81B | $1.90B | $1.90B | $1.90B | $1.92B | $2.04B | $2.16B |
| Other non-current liabilities | $75.2M | $71.7M | $67.4M | $63.9M | $63.6M | $61.9M | $73.1M | $74.2M |
| Common stock & paid-in capital | $4.18B | $4.28B | $4.34B | $4.36B | $4.43B | $4.42B | $4.40B | $4.49B |
| Retained earnings | $3.15B | $3.02B | $2.86B | $2.73B | $2.60B | $2.48B | $2.39B | $2.27B |
| Accumulated other comprehensive income (loss) | -$127.3M | -$113.1M | -$42.7M | -$76.1M | -$70.5M | -$292.3M | -$374.2M | -$165.8M |
Cash flow
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $367.1M | $335.4M | $298.2M | $287.8M | $420.0M | $260.8M | $332.8M | $250.8M |
| Investing cash flow | -$108.5M | -$217.2M | -$98.5M | -$88.3M | -$108.5M | -$69.8M | -$123.9M | -$105.3M |
| Financing cash flow | -$213.5M | -$97.9M | -$98.0M | -$159.2M | -$213.1M | -$178.1M | -$214.4M | -$181.0M |
| Free cash flow | $279.6M | $245.2M | $199.5M | $201.3M | $326.4M | $189.9M | $243.6M | $148.9M |
| Capital expenditures | $87.5M | $90.2M | $98.7M | $86.5M | $93.6M | $70.9M | $89.2M | $101.9M |
| Depreciation & amortization | $123.8M | $123.4M | $122.0M | $121.7M | $119.4M | $122.3M | $125.9M | $115.3M |
| Share-based compensation | $12.8M | $12.9M | $15.7M | $21.2M | $11.9M | $9.8M | $15.3M | $20.8M |
| Deferred income taxes | $600.0K | -$16.7M | -$100.0K | -$100.0K | $0 | -$52.7M | -$1.7M | $0 |
| Change in accounts receivable | -$90.0M | $123.5M | $15.5M | $5.3M | -$119.2M | $108.1M | $3.2M | $25.2M |
| Change in inventory | $73.3M | -$38.5M | $1.8M | $18.2M | $42.5M | -$73.8M | -$18.0M | -$15.4M |
| Change in accounts payable | $4.3M | $56.9M | -$28.8M | $13.2M | $9.8M | $41.1M | $8.8M | $800.0K |
| Purchases of investments | $5.0M | $127.2M | $5.0M | $1.8M | $0 | $10.8M | $0 | $0 |
| Other investing activities | — | — | — | — | — | — | — | — |
| Share repurchases | $115.5M | $74.3M | $50.1M | $100.5M | $10.6M | $200.0K | $100.5M | $46.4M |
| Debt repaid | — | — | — | — | — | — | — | — |
| Tax withholding on stock comp | $15.5M | $1.3M | $100.0K | $500.0K | $10.6M | $300.0K | $400.0K | $300.0K |
| Other financing activities | $1.3M | $600.0K | $15.4M | $7.6M | $9.3M | $6.1M | $300.0K | $13.5M |
Income statement
| Line item | Mar '26 | Mar '25 | Mar '24 | Mar '23 | Mar '22 |
|---|---|---|---|---|---|
| Revenue | $5.94B | $5.46B | $5.14B | $4.54B | $4.22B |
| Gross profit | $2.63B | $2.40B | $2.22B | $1.98B | $1.88B |
| Operating income | $1.10B | $866.6M | $836.1M | $791.1M | $477.8M |
| Net income | $782.3M | $614.6M | $378.2M | $107.0M | $243.9M |
| EPS (diluted) | $7.93 | $6.20 | $3.81 | $1.07 | $2.48 |
| EPS (basic) | $7.97 | $6.24 | $3.83 | $1.07 | $2.50 |
| Operating margin | $19 | $16 | $16 | $17 | $11 |
| Net margin | $13 | $11 | $7 | $2 | $6 |
Balance sheet
| Line item | Mar '26 | Mar '25 | Mar '24 | Mar '23 | Mar '22 |
|---|---|---|---|---|---|
| Total assets | $10.74B | $10.15B | $11.06B | $10.82B | $11.42B |
| Total liabilities | $3.54B | $3.53B | $4.75B | $4.73B | $4.88B |
| Stockholders' equity | $7.18B | $6.60B | $6.30B | $6.08B | $6.53B |
| Total current assets | $2.39B | $2.00B | $2.87B | $2.01B | $1.88B |
| Total current liabilities | $1.15B | $1.02B | $931.1M | $861.8M | $922.2M |
| Cash & equivalents | — | — | — | — | — |
| Accounts receivable | $1.09B | $1.04B | $1.01B | $865.0M | $799.0M |
| Inventory | $631.8M | $581.3M | $674.5M | $604.4M | $575.0M |
| Property, plant & equipment | $2.16B | $1.96B | $1.77B | $1.63B | $1.55B |
| Goodwill | $4.19B | $4.10B | $4.07B | $3.88B | $3.94B |
| Intangible assets | $1.62B | $1.85B | $2.12B | $2.08B | $3.33B |
| Other non-current assets | $211.4M | $83.0M | $66.2M | $77.9M | $70.7M |
| Accounts payable | $338.8M | $280.8M | $251.7M | $264.2M | $225.7M |
| Accrued liabilities | $401.9M | $368.1M | $319.7M | $298.0M | $306.5M |
| Short-term debt | $118.9M | $125.0M | $85.9M | $60.0M | $142.9M |
| Long-term debt | $1.81B | $1.92B | $3.12B | $3.02B | $2.95B |
| Other non-current liabilities | $71.7M | $61.9M | $71.5M | $76.1M | $75.6M |
| Common stock & paid-in capital | $4.28B | $4.42B | $4.54B | $4.49B | $4.74B |
| Retained earnings | $3.02B | $2.48B | $2.09B | $1.91B | $2.00B |
| Accumulated other comprehensive income (loss) | -$113.1M | -$292.3M | -$328.7M | -$320.7M | -$209.8M |
Cash flow
| Line item | Mar '26 | Mar '25 | Mar '24 | Mar '23 | Mar '22 |
|---|---|---|---|---|---|
| Operating cash flow | $1.34B | $1.15B | $973.3M | $756.9M | $684.8M |
| Investing cash flow | -$512.5M | $388.8M | -$887.4M | -$383.3M | -$666.6M |
| Financing cash flow | -$568.2M | -$1.57B | -$85.2M | -$498.7M | $115.8M |
| Free cash flow | $972.4M | $778.0M | $613.0M | $395.0M | $397.2M |
| Capital expenditures | $369.0M | $370.1M | $360.3M | $362.0M | $287.6M |
| Depreciation & amortization | $486.5M | $476.2M | $565.2M | $552.9M | $553.1M |
| Share-based compensation | $61.7M | $57.4M | $56.5M | $39.0M | $57.7M |
| Deferred income taxes | -$16.9M | -$76.5M | -$131.4M | -$185.9M | -$106.6M |
| Change in accounts receivable | $25.1M | $28.8M | $128.1M | $133.3M | $52.0M |
| Change in inventory | $24.0M | -$73.1M | $37.5M | $123.9M | $102.9M |
| Change in accounts payable | $51.1M | $33.6M | -$19.0M | $53.3M | $14.9M |
| Purchases of investments | $134.0M | $10.8M | $1.5M | $0 | $0 |
| Other investing activities | — | — | — | $0 | $0 |
| Share repurchases | $235.5M | $211.3M | $11.8M | $308.6M | $55.8M |
| Debt repaid | — | — | — | — | — |
| Tax withholding on stock comp | $12.5M | $11.3M | $11.8M | $13.5M | $30.8M |
| Other financing activities | $32.9M | $25.5M | $10.5M | $1.8M | $10.1M |
Source: SEC EDGAR XBRL filings (10-Q/10-K), as originally tagged by the company. Quarterly cash flow is reconstructed by de-cumulating fiscal-year-to-date figures (how cash flow is tagged in 10-Qs); other quarterly lines are reported directly.
Institutional holders
SEC Form 13F filers holding STE as of the latest reported quarter. 13F only covers investment managers with $100M+ in assets — this is not a complete ownership picture, and does not include insiders (see Recent SEC filings below) or non-13F-eligible holders.
Institutional ownership is not available for this symbol right now.
Insider activity
Directors, officers, and 10%+ owners' reported transactions from SEC Form 4. A filing reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR Form 4 filings · checked 25 most recent filings · covers 2026-06-03 to 2026-10-01
Recent transactions
- Insiders have net sold 9,905 shares over the last 182 days, across 0 purchases and 4 sales.
- Most recent: Burton Karen L (Sr. Vice Pres., CFO) — Tax withholding of 228 shares on 2026-10-01.
Deterministic template sentences filled in from the SEC Form 4 figures in the tables below -- not an AI-written summary, no live model call.
Insider purchases & sales, last 6 months
Purchases (open market)0 sh(0 txns)
Sales (open market)9,905 sh(4 txns)
Net Shares-9,905
Counts only open-market purchases (code P) and sales (code S) — grants, option exercises, tax withholding, and gifts are excluded since they aren't a market buy/sell decision.
Insider roster
| Name | Title | Most Recent Transaction | Date | Shares |
|---|---|---|---|---|
| Burton Karen L | Sr. Vice Pres., CFO | Tax withholding | 2026-10-01 | 228 |
| Sohi Mohsen | Director | Option exercise | 2026-08-12 | 4,058 |
| Zangerle John Adam | Sr. VP, Gen Counsel, and Sec. | Open market sale | 2026-06-15 | 1,419 |
| Carestio Daniel A | President and CEO | Open market sale | 2026-06-05 | 1,374 |
| Tamaro Renato | V.P. & Corporate Treasurer | Tax withholding | 2026-06-04 | 65 |
| Madsen Julia | Sr. VP and GM, Life Sciences | Tax withholding | 2026-06-04 | 195 |
| Kohler Kenneth E | SVP & GM, AST | Tax withholding | 2026-06-04 | 150 |
| Fraser Mary Clare | SVP & Chief HRO | Tax withholding | 2026-06-04 | 600 |
Recent transactions
| Date | Insider | Title | Transaction | Shares | Price |
|---|---|---|---|---|---|
| 2026-10-01 | Burton Karen L | Sr. Vice Pres., CFO | Tax withholding | 228 | $0.00 |
| 2026-08-12 | Sohi Mohsen | Director | Option exercise | 4,058 | $86.23 |
| 2026-08-12 | Sohi Mohsen | Director | Open market sale | 4,058 | $235.78 |
| 2026-07-01 | Sohi Mohsen | Director | Option exercise | 3,781 | $71.40 |
| 2026-07-01 | Sohi Mohsen | Director | Tax withholding | 1,837 | $212.30 |
| 2026-06-15 | Zangerle John Adam | Sr. VP, Gen Counsel, and Sec. | Open market sale | 1,419 | $209.28 |
| 2026-06-05 | Carestio Daniel A | President and CEO | Open market sale | 1,374 | $212.00 |
| 2026-06-04 | Zangerle John Adam | Sr. VP, Gen Counsel, and Sec. | Tax withholding | 401 | $212.24 |
| 2026-06-04 | Tamaro Renato | V.P. & Corporate Treasurer | Tax withholding | 65 | $212.24 |
| 2026-06-04 | Madsen Julia | Sr. VP and GM, Life Sciences | Tax withholding | 195 | $212.24 |
| 2026-06-04 | Kohler Kenneth E | SVP & GM, AST | Tax withholding | 150 | $212.24 |
| 2026-06-04 | Fraser Mary Clare | SVP & Chief HRO | Tax withholding | 600 | $212.24 |
| 2026-06-04 | Carestio Daniel A | President and CEO | Tax withholding | 1,889 | $212.24 |
| 2026-06-04 | Carestio Daniel A | President and CEO | Open market sale | 3,054 | $214.64 |
| 2026-06-04 | Burton Karen L | Sr. Vice Pres., CFO | Tax withholding | 90 | $212.24 |
| 2026-06-03 | Zangerle John Adam | Sr. VP, Gen Counsel, and Sec. | Tax withholding | 365 | $210.19 |
| 2026-06-03 | Tamaro Renato | V.P. & Corporate Treasurer | Tax withholding | 64 | $210.19 |
| 2026-06-03 | Madsen Julia | Sr. VP and GM, Life Sciences | Tax withholding | 239 | $210.19 |
| 2026-06-03 | Kohler Kenneth E | SVP & GM, AST | Tax withholding | 184 | $210.19 |
| 2026-06-03 | Fraser Mary Clare | SVP & Chief HRO | Tax withholding | 311 | $210.19 |
| 2026-06-03 | Carestio Daniel A | President and CEO | Tax withholding | 2,619 | $210.19 |
| 2026-06-03 | Burton Karen L | Sr. Vice Pres., CFO | Tax withholding | 190 | $210.19 |
Recent SEC filings
Official company reports and insider transaction filings. Form 4 reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR submissions · updated 2026-10-22 04:56 UTC
| Filed | Form | Report period | Official filing |
|---|---|---|---|
| 2026-10-13 | 8-K | 2026-10-11 | View on SEC.gov → |
| 2026-10-05 | 4 | 2026-10-01 | View on SEC.gov → |
| 2026-08-12 | 4 | 2026-08-10 | View on SEC.gov → |
| 2026-08-12 | 4 | 2026-08-10 | View on SEC.gov → |
| 2026-08-12 | 4 | 2026-08-10 | View on SEC.gov → |
| 2026-08-12 | 4 | 2026-08-10 | View on SEC.gov → |
| 2026-08-12 | 4 | 2026-08-10 | View on SEC.gov → |
| 2026-08-12 | 4 | 2026-08-10 | View on SEC.gov → |
| 2026-08-12 | 4 | 2026-08-10 | View on SEC.gov → |
| 2026-08-12 | 4 | 2026-08-10 | View on SEC.gov → |
| 2026-08-07 | 10-Q | 2026-06-30 | View on SEC.gov → |
| 2026-08-06 | 8-K | 2026-07-31 | View on SEC.gov → |
Recent news
Headlines about STE (STERIS plc). Links open the publisher — we don’t host full articles.
-
STERIS plc (STE) Stock Price, News, Quote & History
Yahoo! Finance Canada · 2026-10-21 -
Steris PLC stock outperforms competitors on strong trading day
MarketWatch · 2026-10-20 -
Steris plc to host Q2FY27 earnings conference call on Nov 5
scanx.trade · 2026-10-20 -
STERIS to Host a Conference Call for Fiscal 2027 Second Quarter on November 5, 2026
Yahoo · 2026-10-20 -
STERIS (STE) Stock Looks Fairly Priced After Big Expansion Plans
Simply Wall Street · 2026-10-20 -
STERIS stock trades at EUR 197.65 with USD 21.6 billion value - ad-hoc-news.de
ad-hoc-news.de · 2026-10-20 -
STE Nov 2026 190.000 put (STE261120P00190000) Stock Price, News, Quote & History
Yahoo! Finance Canada · 2026-10-19 -
STERIS plc $STE Stock Holdings Increased by Assenagon Asset Management S.A.
MarketBeat · 2026-10-19
No headlines in this category right now — try “All”.